Parameter
| Biomarker | Circulating Tumor Cells (CTCs) | Full name | Circulating Tumor Cells | Molecular Type | Cells |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | |||
| Disease | Hepatocellular Carcinoma (HCC) | Disease Subtypes | / | ||
| Organ | Liver | Test Sample / Technology Platform | As "seed" of metastasis, through EMT adapt to the environment, promote the distant metastasis | ||
| Pathobiological Mechanisms | Diagnosis, prognosis, monitoring, and prediction of treatment response | ||||
| Clinical Availability Status | Research validation/clinical monitoring tool: EpCAM+CTCs≥2 indicates an increased risk of postoperative recurrence | ||||
| Notes and Dynamics | Combined detection of mRNA can improve the sensitivity, and PD-L1+CTCs are associated with the efficacy of immunotherapy | ||||